中山痔疮怎么办快速治疗(中山痔疮手术几天) (今日更新中)

WASHINGTON, April 13 (Xinhua) -- The U.S. Food and Drug Administration (FDA) announced on Wednesday that it has approved the cPAX Aneurysm Treatment System for surgery on brain aneurysms that are difficult to manage because of their size and shape.An aneurysm is a bulge in the wall of a blood vessel, which can rupture as it increases in size, causing hemorrhage or death. Brain aneurysms often produce no symptoms until they grow and press on nerves in the brain, or until they begin to leak blood or rupture.Aneurysms can be repaired in two ways: surgeons can close the base of the aneurysm with a surgical clip, or use a technique commonly known as coiling, in which surgeons use a catheter to thread metallic coils through a blood vessel in the groin and into the blood vessel in the brain that contains the aneurysm. Surgeons then fill the aneurysm with the detachable coils, which block it from circulation and cause blood to clot, effectively destroying the aneurysm.Aneurysms larger than 10 millimeters are difficult to treat with clipping or coiling. The cPAX device system is indicated for use in those brain aneurysms."Like coiling, the cPAX Aneurysm Treatment System is a form of endovascular repair," said Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health. "But instead of tiny metallic coils, it uses a special polymer material to fill the space within the aneurysm."According to the FDA, the cPAX device system is indicated for use in adults aged 22 and older and should not be used in patients with an active infection or in those in whom anticoagulation and antiplatelet therapy is contraindicated.

BEIJING, Jan. 21 (Xinhua) -- Chinese Vice Premier Li Keqiang on Friday stressed the importance that local governments improve management of land and resources, as it remains vital for the stable and relatively quick development of the nation's economy.Li said China faced the difficult tasks of land and resource management as resources are becoming scarce amid the country's quickening industrialization, urbanization, and agricultural modernization.He said the nation must continue preserving arable land. To ensure grain security, China set a "red line" to guarantee its arable land never shrinks to less than 1.8 billion mu (120 million hectares).Chinese Vice Premier Li Keqiang (R) shakes hands with outstanding representatives from local departments in charge of land and resources in Beijing, capital of China, Jan. 21, 2011.Li also called on local authorities to step up efforts to protect valuable mineral resources while using resources more efficiently and in a frugal manner.At the same time, the senior Chinese official said land should be guaranteed for the nation's plan to build 10 million affordable houses for low and middle income people this year.Further, Li urged local authorities to improve work in monitoring and taking precautionary measures against geological disasters to ensure the safety of people's lives and property.

BRASILIA, April 26 (Xinhua) -- A survey conducted by Brazil's Ministry of Health showed Tuesday that half of Brazilians aged over 55 have hypertension.According to the research, which has been carried out annually since 2006, the proportion of Brazilians diagnosed with hypertension increased over the past five years, from 21.6 percent in 2006 to 23.3 percent in 2010.Besides, the diagnosis of hypertension is higher among women (25.5 percent) than men (20.7 percent). But in both sexes, the older people are, the more common the disease becomes, the ministry reported.The ministry also said that, to address the problem, the Brazilian government distributes free medicines to control blood pressure, since 80 percent of Brazilians who suffer from hypertension depend on the public health system.The Ministry of Health signed on April 7 an agreement with the food industry, aiming to reduce salt in processed food.If hypertension is left untreated, some complications including clogged arteries, stroke and myocardial infarction will bring patients more troubles.

CHENGDU, May 8 (Xinhua) -- As a brand-name herbal capsule for cardiovascular disease in China, Di'ao Xinxuekang only needs to wait for another 15 years before reaching the EU market."The Dutch medical supervisors have recognized it as a qualified drug, but we still lack the evidence of 15-year presence in the EU market," said Ji Jianxin, a research manager with the drug's developer Di'ao Group based in southwest China's Sichuan Province.Di'ao, one of the largest Traditional Chinese Medicine (TCM) manufacturers, has been quite depressed, as many other TCM enterprises in China, by a European Union directive on traditional herbal medicinal products fully implemented from the beginning of this month.The directive requires that all herbal medicinal products, must obtain a medical license from any EU member state before it can be allowed in the EU market.It introduced a so-called simplified registration procedure with a seven-year transition period for traditional herbal medicinal products to be licensed, including Chinese and Indian ones.However, not a single Chinese herbal medicinal product has been granted the license so far, mainly due to the prohibitive registration cost and lack of required evidence to prove the product had a 30-year history of safe use, including 15 years in the EU.With a history of more than 2,000 years, TCM did not enter into the EU market until mid-1990s, and it has been imported into the EU and sold to European customers as food supplements instead of drugs.Most Chinese producers and importers did not reserve the customs papers a decade ago, thus unable to prove the 15-year use of their products in European markets.While TCM's globalization won't be doomed by one single EU directive as TCM export value to EU only takes up 14 percent of the total in 2010, experts and industry insiders still have had serious concerns about its future."Most TCM even don't have standardized labels that can help consumers to find out its origin," said Xian Sheng, from the China Association of TCM Export Companies.

MOSCOW, Jan. 24 (Xinhua) -- Russian President Dmitry Medvedev and visiting Chinese State Councilor Dai Bingguo held talks here on Monday, discussing prospects for the development of cooperation between the two countries.Medvedev and Dai Bingguo discussed the development of Russian- Chinese bilateral cooperation and interaction on the international arena.The Russian president said the Sino-Russian strategic partnership of coordination is developing further in all aspects, as the leaders of the two nations kept close contact during last year and cooperation in the economic and trade sphere has been deepened.Russia sees China as its closest partner, a position that will never be changed, Medvedev stressed.Russia is willing to work together with China to promote all- around cooperation and coordination on international and regional issues, Medvedev said.He said the strategic security talks between Russia and China, a major goal of Dai's current visit, have served as an important channel for bilateral coordination and exchanges, and played a pivotal role in enhancing bilateral strategic mutual trust.Dai Bingguo, who arrived in Moscow Sunday for a three-day visit, said that the first ten years of the 21st century had been important for Sino-Russian relations.China attaches great importance to the strategic coordination with Russia and is willing to work with Russia to develop their strategic partnership of coordination at a higher stage, the Chinese state councilor said.

来源：资阳报